Sensex, Nifty opening: Will stock market rise or fall today?

Benchmark stock market indices are set to open higher on Monday, attempting to snap a three-session losing streak, even as concerns around rising crude oil prices and continued foreign investor selling keep sentiment cautious.

GIFT Nifty futures were trading at 24,143.50 as of 8:15 am, indicating a gap-up opening of nearly 1% compared to Friday’s close of 23,897.95.

Aakash Shah, Technical Research Analyst at Choice Equity Broking, said markets are likely to open on a positive note but may remain volatile.

“Equity markets are expected to open on a positive note, tracking firm cues from GIFT Nifty, which is currently trading around 24,140, up by nearly 185 points, indicating a gap-up start for domestic benchmark indices,” he said.

He added that despite the positive opening, the overall trend remains cautious.

The expected recovery comes after both Sensex and Nifty fell around 2.7% each over the last three sessions, pressured by rising oil prices linked to the Iran conflict and weak earnings outlook from IT majors such as Infosys and HCLTech.

OIL PRICES REMAIN ELEVATED

Crude oil prices continue to remain a key concern for markets. As of around 8:30 am, Brent crude was trading near $106–$107 per barrel, while WTI crude was around $95, reflecting sustained pressure due to stalled US–Iran peace talks and supply disruptions in the Middle East.

Higher oil prices raise concerns about inflation, input costs and overall economic growth, especially for an import-dependent country like India.

FII SELLING ADDS TO CAUTION

Foreign institutional investors (FIIs) have remained net sellers for five consecutive sessions. On Friday alone, FIIs sold equities worth Rs 8,827 crore, while domestic institutional investors (DIIs) bought shares worth Rs 4,700 crore, offering some support to the market.

This divergence reflects continued caution among global investors despite domestic buying at lower levels.

Investors will closely watch key stocks such as Reliance Industries and Axis Bank.

Reliance Industries missed its quarterly profit estimates, impacted by higher input costs and supply disruptions linked to the Iran conflict.

Axis Bank also reported a marginal decline in fourth-quarter profit due to lower treasury income and higher provisions.

Asian markets rose around 1.5%, led by gains in South Korean stocks, tracking a rally in US technology shares after strong earnings from Intel.

Markets will also keep an eye on upcoming results from global tech giants such as Amazon, Alphabet and Meta, which could influence sentiment in the technology sector.

“The Nifty 50 continues to trade with a negative to sideways bias in the short term. Immediate support is placed around 23,900–23,800 levels, while resistance is seen at 24,200. A sustained move above 24,200 is necessary to revive bullish momentum,” Shah said.

Markets are likely to see range-bound and volatile trade during the day.

While lower valuations after the recent correction may provide some support, rising oil prices, geopolitical tensions and continued FII selling are expected to keep investors cautious in the near term.

Latest

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Topics

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Cursor AI Agent wipes out startup database in 9 seconds, founder shares 30-hour chaos timeline

A startup founder said Cursor AI Agent erased the company database in nine seconds. The account traced 30 hours of disruption after the incident.

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp
spot_img

Related Articles

Popular Categories

spot_imgspot_img